Effects of Myofascial Release and TENS Over Pain, Hand Prehensile Strength and Functionality of Superior Extremity in Women With Lateral Epicondylalgia

July 16, 2019 updated by: Fernanda Merino Alvarez

Effects of Myofascial Release of the Brachial Biceps and TENS Over the Elbow Pain, Hand Prehensile Strength and Functionality of Superior Extremity in Women With Symptomatology of Chronic Lateral Epicondylalgia

This study evaluated the additive effect of myofascial release therapy on the brachial biceps on conventional management (TENS) in pain intensity, hand prehensile strength and upper limb functionality of individuals with lateral epicondylalgia.

Study Overview

Status

Completed

Detailed Description

This study determined the additive effect of the myofascial release therapy of brachial biceps on TENS in the variables pain intensity, hand prehensile strength and upper limb functionality of individuals with lateral epicondylalgia, compared to a group that received only TENS. This was done in a sample of 32 individuals, assigned in two groups: group A that received an application of TENS and group B that received an application of TENS plus myofascial release therapy.

Contrary to the hypothesis, the application of myofascial release therapy added to the application of TENS proved to generate a significant change only in the prehensile hand force with respect to the group that received only TENS.

Study Type

Interventional

Enrollment (Actual)

32

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Concepción
      • Talcahuano, Concepción, Chile, 4260000
        • Universidad Andrés Bello

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Female between 30 and 50 years old.
  • Belong to the administrative staff of the university in question
  • Have a symptomatic diagnosis of chronic lateral epicondylitis (> 6 weeks)

Exclusion Criteria:

  • Being pregnant
  • Have done moderate or intense aerobic or anaerobic sport activities of any kind 72 hours before the registrations
  • Have an orthopedic, rheumatologic, neuropsychiatric or associated comorbidities diagnosed.
  • Have suffered a fracture or trauma involving the upper extremity 4 months before the intervention.
  • Be in medical, pharmacological or kinesthetic treatment during the intervention or 2 weeks before this.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: TENS
Conventional TENS of 100 Hz and 100 usec for 20 minutes
100 Hz and 100 usec for 20 minutes
Other Names:
  • Transcutaneous electrical nerve stimulation
Experimental: Myofascial Therapy
Conventional TENS of 100 Hz and 100 usec for 20 minutes plus myofascial release therapy in the brachial biceps; Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding
100 Hz and 100 usec for 20 minutes
Other Names:
  • Transcutaneous electrical nerve stimulation
Seven to fifteen transverse sliding repetitions and three repetitions of longitudinal sliding of myofascial release therapy

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in pain intensity numerical rating scale
Time Frame: One month
Self-reported measure of pain intensity. It consists on asking to assess pain intensity by selecting a number on a scale of 11 horizontal points. It is represented from 0 (without pain) to 10 (the worst possible pain) A score of 1 to 4 indicates mild pain; 5-6, moderate pain; and 7 to 10, severe pain.
One month
Pressure pain threshold
Time Frame: Immediately after treatment
Is the minimum pressure that induces pain or discomfort. It was measured with a algometer. It is expressed in units of pressure as kilograms per square centimeter per second (Kg / cm2 / s).
Immediately after treatment
Prehensile hand strength
Time Frame: Immediately after treatment
It is the ability to compress the hand, related to the functional integrity of the upper extremity as an index of general health. It was measured with a dynamometer. It was measured according to the criteria established by the American Society of Hand Therapists. It is measured in kilograms
Immediately after treatment
Change in Elbow functionality.
Time Frame: One month

Functionality is a generic term that includes bodily functions, body structures, activities and participation. It shows the positive aspects of a person's interaction and the context. It was obtained through a scale of functionality (Oxford Elbow Score), which is composed of three domains (subscales); elbow, pain and social-psychological function, which underlie 12 questions, which are internally consistent, one-dimensional and do not have redundancy of items.

The scores of each domain are calculated as the sum of the score of each individual element, where each case is expressed on a scale from 0 to 100 where, a score of 0.84 indicates a substantial improvement.

One month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Jorge Fuentes, PhD, Universidad Andrés Bello

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 24, 2018

Primary Completion (Actual)

October 22, 2018

Study Completion (Actual)

December 20, 2018

Study Registration Dates

First Submitted

July 7, 2019

First Submitted That Met QC Criteria

July 16, 2019

First Posted (Actual)

July 17, 2019

Study Record Updates

Last Update Posted (Actual)

July 17, 2019

Last Update Submitted That Met QC Criteria

July 16, 2019

Last Verified

July 1, 2019

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Musculoskeletal Manipulations

Clinical Trials on TENS

3
Subscribe